FDA Surrenders in TIRF War


Were you expecting TURF instead of TIRF? This is not a typo. TIRF stands for transmucosal immediate-release fentanyl.
We all know about these fentanyl sprays, tablets and lozenges, and that they are a risky narcotic 50 times stronger than heroin and up to 100 times stronger than morphine. Generally their label use is for cancer patients with high opioid tolerance.
Emily Baumgaertner, writing in The New York Times, explains how these drugs are being prescribed for back pain and migraines, and how the FDA did little to monitor or curb inappropriate use. Essentially, the FDA entrusted Big Pharma (that makes and sells the drugs) to provide the oversight.
Brandeis University opioid policy researcher Dr. Andrew Kolodny is quoted as follows: “They had the fox guarding the henhouse, people were getting hurt — and the FDA sat by and watched this happen.”
Gee, I wonder if the fact that a month’s worth of prescription can cost tens of thousands of dollars made a difference to the fox that was guarding the henhouse?
Big Pharma will not do better. Regulatory agencies are well-meaning, but…
…Pharmaceutical UR is the key.
Call us. We can do better.
William Faris, JD
Chief Executive Officer

Posted in Medical Cost Containment, OMCA, Workers’ Compensation